| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/25/2008 | US20080233651 Method and medicament for inhibiting the expression of a given gene |
| 09/25/2008 | US20080233650 Tetracycline operon repressor protein transfection; replication-deficient; veterinary medicine |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233646 Human DR4 antibodies and uses thereof |
| 09/25/2008 | US20080233644 Chimeric Transcription Factor Decoy Oligonucleotides |
| 09/25/2008 | US20080233642 Mammalian immortalized liver cell |
| 09/25/2008 | US20080233639 Fusion protein delivery system and uses thereof |
| 09/25/2008 | US20080233638 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233635 particle differentiation device; identifying and separating sperm cells according to chromosomal complement; photomultiplier tube converts light from light emission source into one differentiation signal; cattle, sheep, and/or horse in vitro fertilization and veterinary medicine |
| 09/25/2008 | US20080233629 Fusion protein for use in genration of preferential biopolymers in plants |
| 09/25/2008 | US20080233628 Incorporation of type III polyketide synthases into multidomain proteins of the type I and III polyketide synthase and fatty acid synthase families |
| 09/25/2008 | US20080233627 Nicotianamine synthase and gene encoding the same |
| 09/25/2008 | US20080233621 inexpensive and efficient industrial method for obtaining (S)-2-pentanol, (S)-2-hexanol, 1-methylalkyl malonic acid and 3-methyl carboxylic acid at a high optical purity; carbonyl reductase to act on 2-pentanone or 2-hexanone |
| 09/25/2008 | US20080233620 transformant is obtained by introducing a plurality of enzyme genes involved with polyhydroxyalkanoic acid synthesis such as a polyhydroxyalkanoic acid synthase gene and an acetoacetyl CoA reductase gene into said gene-disrupted yeast |
| 09/25/2008 | US20080233618 Isolated, purified genetic engineered DNA; culturing a host cell to produce polyketide |
| 09/25/2008 | US20080233615 stress-related fusion proteins, antigenic peptides, and anti-stress-related antibodies; nucleic acid molecule encodes polypeptide which increases bile tolerance of cell; Lactobacillus acidophilus cell with an increased ability to survive stressful conditions compared to a wild-type |
| 09/25/2008 | US20080233614 codon-optimized genes designed to help maximize expression level; making collegenase |
| 09/25/2008 | US20080233613 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 09/25/2008 | US20080233611 pairs of orthogonal-tRNAs (O-tRNAs) and orthogonal aminoacyl-tRNA synthetases (O RSs) that do not interact with the host cell translation machinery |
| 09/25/2008 | US20080233610 by administering at least one or a plurality of potency-determining factors; not c-Myc and Klf4; at least one putative potency-determining factor is Oct-4, Sox2 and at least one of Nanog and Lin28 |
| 09/25/2008 | US20080233608 Genes and proteins involved in lipid remodeling of gpi-anchored proteins and the use thereof |
| 09/25/2008 | US20080233598 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/25/2008 | US20080233596 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 09/25/2008 | US20080233595 Method for diagnosing intertility |
| 09/25/2008 | US20080233591 enables assessment of dynamic variations in a mixed population of organisms using affinity aided solution hybridization combined with resolution providing fractionation; very sensitive; allow quantitative detection of polynucleotide sequences present in diminutive amounts |
| 09/25/2008 | US20080233584 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample |
| 09/25/2008 | US20080233580 transgenic mouse model which allows for the simultaneous, tissue-specific and temporally-controlled regulation of transgene expression and can be used as a tool to investigate the consecutive steps involved in initiation and progression of certain diseases such as cancer, but particularly lung cancer |
| 09/25/2008 | US20080233574 Use of mRNA transcripts, and variation in transcript levels for the identification of quantitative trait loci pertaining to a desired trait within an organism; exhibiting a measurable response to an environmental stimulus or phenotype of interest |
| 09/25/2008 | US20080233565 PKHDL1, a homolog of the autosomal recessive kidney disease gene |
| 09/25/2008 | US20080233560 DNA-transfection system for the generation of infectious influenza virus |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233154 Immunoprotective and nontoxic Gram-negative bleb vaccine suitable for paediatric use; Neisseria meningitides; H. influenzae |
| 09/25/2008 | US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233138 Coccidiosis Poultry Vaccine |
| 09/25/2008 | US20080233130 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; surface plasmon resonance; treating allergic hypersensitivity |
| 09/25/2008 | US20080233129 Ligand that has binding specificity for IL-4 and/or lL-13 |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233123 Polypeptide from haemophilus influenzae |
| 09/25/2008 | US20080233122 Complementarity determining regions; immunoglobulins; cell line, host cells; transgenic animals, plants |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
| 09/25/2008 | US20080233116 Human monoclonal antibodies to CTLA-4 |
| 09/25/2008 | US20080233114 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 09/25/2008 | US20080233111 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection |
| 09/25/2008 | US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2008 | US20080233109 Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
| 09/25/2008 | US20080233104 Probiotic, lactic acid-producing bacteria and uses thereof |
| 09/25/2008 | US20080233103 Mycobacterial peptide deformylase |
| 09/25/2008 | US20080233100 Targeted enzymes |
| 09/25/2008 | US20080233097 different phosphorylation site is the threonine residue in position 123 (Thr123) of mouse or human p38, alpha isoform; diagnostic marker of pathologies mediated by MAPKs |
| 09/25/2008 | US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/25/2008 | US20080233090 Method of Treatment by Administration of Rna |
| 09/25/2008 | US20080233089 Modified Cells Expressing a Protein That Modulates Activity of Bhlh Proteins, and Uses Thereof |
| 09/25/2008 | US20080233086 Expression Vectors for Treating Bacterial Infections |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | US20080230399 Fructosylamine Oxidase |
| 09/25/2008 | DE102007014742A1 Isoformen der Schweineleber Esterase Isoforms of porcine liver esterase |
| 09/25/2008 | CA2693847A1 Bladder cancer diagnosis and/or prognosis method |
| 09/25/2008 | CA2688938A1 Materials and methods for efficient succinate and malate production |
| 09/25/2008 | CA2684578A1 Chimeric antigens |
| 09/25/2008 | CA2682112A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | CA2681634A1 Methods and compositions related to riboswitches that control alternative splicing |
| 09/25/2008 | CA2681522A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | CA2681415A1 Mutant g-protein coupled receptors and methods for selecting them |
| 09/25/2008 | CA2681406A1 Rna antagonist compounds for the inhibition of apo-b100 expression |
| 09/25/2008 | CA2681323A1 Combined hairpin-antisense compositions and methods for modulating expression |
| 09/25/2008 | CA2681193A1 Pericycle-specific expression of microrna167 in transgenic plants |
| 09/25/2008 | CA2681035A1 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 09/25/2008 | CA2680787A1 Compositions and methods for reducing h2s levels in fermented beverages |
| 09/25/2008 | CA2680708A1 Metal-binding therapeutic peptides |
| 09/25/2008 | CA2680368A1 A method of treating malignant mesothelioma |
| 09/25/2008 | CA2678946A1 Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
| 09/24/2008 | EP1972937A1 Probe array substrate, method of producing the same and method of producing probe array |
| 09/24/2008 | EP1972935A1 Screening method for infectious agent of prion disease |
| 09/24/2008 | EP1972690A1 Desaturase antigen of mycobacterium tuberculosis |
| 09/24/2008 | EP1972689A2 A mutated immunoglobulin-binding protein |
| 09/24/2008 | EP1972688A1 Method of amplifying nucleic acid from microorganism using nonplanar solid substrate |
| 09/24/2008 | EP1972686A1 Crystal structure of dicamba monooxygenase (DMO) and uses thereof |
| 09/24/2008 | EP1972640A1 Apoptosis inducing antibodies |
| 09/24/2008 | EP1972635A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 09/24/2008 | EP1972194A1 Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 09/24/2008 | EP1971689A2 Gene promoters that can be used in plants |
| 09/24/2008 | EP1971688A2 Dsrna as insect control agent |
| 09/24/2008 | EP1971687A2 Dsrna as insect control agent |
| 09/24/2008 | EP1971686A2 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |
| 09/24/2008 | EP1971685A1 A method for developing a tissue proteome library |
| 09/24/2008 | EP1971684A1 Chimaeric fusion protein with superior chaperone and folding activities |
| 09/24/2008 | EP1971683A2 Adenylate cyclase, gene sequence coding for adenylate cyclase, vectors and cells, and the use thereof |
| 09/24/2008 | EP1814378A4 Casein kinase stress-related polypeptides and methods of use in plants |
| 09/24/2008 | EP1670906B1 Acylglycerol acyltransferase-like protein mgat-x1 and uses thereof |
| 09/24/2008 | EP1521771B1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
| 09/24/2008 | EP1485483B1 Proteolysis resistant active vegf |
| 09/24/2008 | EP1446139B1 Pharmaceutical composition containing soluble fcgamma receptor iib |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | EP1385544B1 Humanized antibodies |
| 09/24/2008 | EP1383903B1 Methods for the production of ascorbic acid intermediates in host cells |
| 09/24/2008 | EP1368476B1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/24/2008 | EP1352068B1 Bacillus thuringiensis insecticidal proteins |